Mochida Pharmaceutical Co. Ltd
Mochida Pharmaceutical Co., Ltd. manufactures and sells pharmaceuticals and healthcare products in Japan. It offers pharmaceuticals products for the treatment of cardiovascular, obstetrics, gynecology, dermatology, psychiatry, and gastroenterology, including Lialda, Omvoh, and Cortiment for the treatment of ulcerative colitis; Goofice and Movicol for the treatment of chronic constipation; Epadel … Read more
Market Cap & Net Worth: Mochida Pharmaceutical Co. Ltd (MFY)
Mochida Pharmaceutical Co. Ltd (F:MFY) has a market capitalization of $691.39 Million (€673.56 Million) as of March 18, 2026. Listed on the F stock exchange, this Germany-based company holds position #10751 globally and #1151 in its home market, demonstrating a -2.06% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Mochida Pharmaceutical Co. Ltd's stock price €19.00 by its total outstanding shares 35450469 (35.45 Million).
Mochida Pharmaceutical Co. Ltd Market Cap History: 2015 to 2026
Mochida Pharmaceutical Co. Ltd's market capitalization history from 2015 to 2026. Data shows change from $1.16 Billion to $691.39 Million (-2.65% CAGR).
Mochida Pharmaceutical Co. Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Mochida Pharmaceutical Co. Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.01x
Mochida Pharmaceutical Co. Ltd's market cap is 0.01 times its annual revenue
1.02x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
0.12x
Mochida Pharmaceutical Co. Ltd's market cap is 0.12 times its annual earnings
10.35x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $1.17 Billion | $92.27 Billion | $8.15 Billion | 0.01x | 0.14x |
| 2017 | $1.14 Billion | $97.35 Billion | $8.53 Billion | 0.01x | 0.13x |
| 2018 | $1.26 Billion | $106.75 Billion | $9.02 Billion | 0.01x | 0.14x |
| 2019 | $1.28 Billion | $109.65 Billion | $8.44 Billion | 0.01x | 0.15x |
| 2020 | $1.10 Billion | $101.80 Billion | $4.60 Billion | 0.01x | 0.24x |
| 2021 | $953.39 Million | $103.00 Billion | $8.59 Billion | 0.01x | 0.11x |
| 2022 | $880.61 Million | $110.18 Billion | $10.57 Billion | 0.01x | 0.08x |
| 2023 | $749.61 Million | $103.26 Billion | $6.65 Billion | 0.01x | 0.11x |
| 2024 | $764.17 Million | $102.89 Billion | $4.55 Billion | 0.01x | 0.17x |
| 2025 | $684.11 Million | $105.16 Billion | $5.68 Billion | 0.01x | 0.12x |
Competitor Companies of MFY by Market Capitalization
Companies near Mochida Pharmaceutical Co. Ltd in the global market cap rankings as of March 18, 2026.
Key companies related to Mochida Pharmaceutical Co. Ltd by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #410 globally with a market cap of $53.52 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #457 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #721 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #410 | Zoetis Inc | NYSE:ZTS | $53.52 Billion | $121.68 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.60 |
| #457 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #721 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Mochida Pharmaceutical Co. Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Mochida Pharmaceutical Co. Ltd's market cap moved from $1.16 Billion to $ 691.39 Million, with a yearly change of -2.65%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €691.39 Million | +1.06% |
| 2025 | €684.11 Million | -10.48% |
| 2024 | €764.17 Million | +1.94% |
| 2023 | €749.61 Million | -14.88% |
| 2022 | €880.61 Million | -7.63% |
| 2021 | €953.39 Million | -13.25% |
| 2020 | €1.10 Billion | -14.20% |
| 2019 | €1.28 Billion | +1.38% |
| 2018 | €1.26 Billion | +11.08% |
| 2017 | €1.14 Billion | -2.86% |
| 2016 | €1.17 Billion | +0.80% |
| 2015 | €1.16 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Mochida Pharmaceutical Co. Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $691.39 Million USD |
| MoneyControl | $691.39 Million USD |
| MarketWatch | $691.39 Million USD |
| marketcap.company | $691.39 Million USD |
| Reuters | $691.39 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.